Scientists report that they have discovered inactivation of the gene EZH2 as a driver and inroad to a potential therapeutic target in aggressive pediatric leukemia subtype.
Scientists report that they have discovered inactivation of the gene EZH2 as a driver and inroad to a potential therapeutic target in aggressive pediatric leukemia subtype.